Chemo-immunotherapy mediates durable cure of orthotopic K ras G12D /p53 -/- pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related death in the United States, exhibiting a five-year overall survival (OS) of only 7% despite aggressive standard of care. Recent advances in immunotherapy suggest potential application of immune-based treatment appro...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncoimmunology 2016-09, Vol.5 (9), p.e1213933
Hauptverfasser:	Konduri, Vanaja, Li, Dali, Halpert, Matthew M, Liang, Dan, Liang, Zhengdong, Chen, Yunyu, Fisher, William E, Paust, Silke, Levitt, Jonathan M, Yao, Qizhi Cathy, Decker, William K
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!